These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3561445

  • 1. Demyelination in vivo by Guillain-Barré syndrome and other human serum.
    Brown MJ, Rosen JL, Lisak RP.
    Muscle Nerve; 1987; 10(3):263-71. PubMed ID: 3561445
    [Abstract] [Full Text] [Related]

  • 2. Demyelination induced by serum from patients with Guillain-Barré syndrome.
    Harrison BM, Hansen LA, Pollard JD, McLeod JG.
    Ann Neurol; 1984 Feb; 15(2):163-70. PubMed ID: 6703656
    [Abstract] [Full Text] [Related]

  • 3. In vivo effects of sera from Guillain-Barré subgroups: an electrophysiological and histological study on rat nerves.
    Oomes PG, van der Meché FG, Markus-Silvis L, Meulstee J, Kleyweg RP.
    Muscle Nerve; 1991 Oct; 14(10):1013-20. PubMed ID: 1658645
    [Abstract] [Full Text] [Related]

  • 4. [Electrophysiological and morphological effects of the injection of Guillain-Barré sera in the sciatic nerve of the rat (author's transl)].
    Sumner A, Said G, Idy I, Metral S.
    Rev Neurol (Paris); 1982 Oct; 138(1):17-24. PubMed ID: 7100734
    [Abstract] [Full Text] [Related]

  • 5. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome.
    Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK.
    Ann Neurol; 1982 Jan; 11(1):69-75. PubMed ID: 7059130
    [Abstract] [Full Text] [Related]

  • 6. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
    Sawant-Mane S, Clark MB, Koski CL.
    Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
    [Abstract] [Full Text] [Related]

  • 7. [Effector mechanisms of PNS demyelination in Gal-C induced-EAN].
    Saida K.
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1361-3. PubMed ID: 2129197
    [Abstract] [Full Text] [Related]

  • 8. Absence of antimyelin antibodies and serum demyelinating factors in most patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    McCombe PA, Pollard JD, McLeod JG.
    Clin Exp Neurol; 1988 Dec; 25():53-60. PubMed ID: 3267485
    [Abstract] [Full Text] [Related]

  • 9. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
    Buchwald B, Toyka KV, Zielasek J, Weishaupt A, Schweiger S, Dudel J.
    Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
    [Abstract] [Full Text] [Related]

  • 10. Humoral mechanisms in immune neuropathies.
    Koski CL.
    Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
    [Abstract] [Full Text] [Related]

  • 11. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
    Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC.
    Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
    [Abstract] [Full Text] [Related]

  • 12. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
    Nomura K.
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL.
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
    Sharief MK, McLean B, Thompson EJ.
    Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J, Hughes RA.
    J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
    [Abstract] [Full Text] [Related]

  • 17. In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study.
    Saida K, Saida T, Brown MJ, Silberberg DH.
    Am J Pathol; 1979 Apr; 95(1):99-116. PubMed ID: 434114
    [Abstract] [Full Text] [Related]

  • 18. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
    Koski CL.
    Ann Neurol; 1990 Apr; 27 Suppl():S44-7. PubMed ID: 2194426
    [Abstract] [Full Text] [Related]

  • 19. Abnormal serum factors in Guillain-Barré syndrome.
    Lisak RP, Brown MJ, Summer AJ.
    Ital J Neurol Sci; 1983 Sep; 4(3):265-72. PubMed ID: 6358121
    [Abstract] [Full Text] [Related]

  • 20. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
    Koski CL, Chou DK, Jungalwala FB.
    J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.